President Signs Cook Supported “Right to Try” Legislation into Law
WASHINGTON- Today, President Trump signed S. 204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act. Rep. Paul Cook (R-Apple Valley) voted for this legislation which passed the House with bipartisan support last week. It had previously passed in the Senate with overwhelming bipartisan support.
This bill amends the Federal Food, Drug, and Cosmetic Act to exempt the provision of certain unapproved, experimental drugs to a terminally ill patient who has exhausted approved treatment options and is unable to participate in a clinical trial involving the drugs.
The Right to Try Act ensures that terminally ill patients and their doctors are allowed to try experimental treatments when no alternatives exist. The manufacturer or sponsor of an eligible drug must report annually to the Food and Drug Administration (FDA) on any use of the drug in accordance with these provisions. The FDA will also be required to post an annual summary report of such use on its website.
Since 2014, 38 states have passed “right to try” laws to bypass FDA permission for access to experimental drugs.
Rep. Cook said, “I’m pleased President Trump has signed this into law. Too many terminally ill patients are denied access to experimental drugs that could help them. This will ensure patients who have life-threatening illnesses have a chance to access potentially life-saving drugs.”
A member of the House Natural Resources, Armed Services, and Foreign Affairs Committees, Cook served as an infantry officer and retired after 26 years as a Colonel in the U.S. Marine Corps. During his time in combat, he was awarded the Bronze Star and two Purple Hearts.